JNJ Press releases
News
In the media
Janssen on driving R&D innovation with data science
Read full storyIn the media
Mestag Therapeutics
Read full storyJNJ Press releases
LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER RESULTS
Read full storyJNJ Press releases
New report reveals strength of the UK’s thriving genomics sector
Read full storyJNJ Press releases
MESTAG THERAPEUTICS EXTENDS SEED FINANCING TO $45 MILLION AND WELCOMES NEW INVESTORS FORBION, GV (FORMERLY GOOGLE VENTURES) AND NORTHPOND VENTURES
Read full storyIn the media
Johnson & Johnson: The Leading Healthcare Group at the Forefront of Open Innovation
Read full storyIn the media
Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland
Read full storyIn the media
Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine
Read full storyIn the media
Investing in innovation – new digital approaches for a new decade
Read full storyIn the media
BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs
Read full storyIn the media
As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on
Read full storyIn the media
The Startup Slam, a Highlight at BIO-Europe 2019
Read full storyIn the media
At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience
Read full storyIn the media